Skip to main
PBH

PBH Stock Forecast & Price Target

PBH Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Prestige Consumer Healthcare is anticipated to experience significant growth, with an increased EBITDA estimate for 2026 and 2027 projected to rise by approximately $15 million, driven by heightened sales growth. The company is expected to see an acceleration in organic volume growth rate for specialty foods in the latter half of 2025, supported by numerous product launches, including one of its largest initiatives to date. Additionally, the firm is likely to benefit from improved free cash flow and enhanced EBITDA growth as it exits a prolonged capital expenditure cycle, while U.S. consumer spending is also expected to strengthen, further contributing to positive financial outcomes.

Bears say

Prestige Consumer Healthcare faces a negative outlook due to anticipated lower-than-expected revenue growth and potential EBITDA margin compression driven by persistent high input costs. The company's reliance on North America for approximately 85% of its revenue exposes it to risks associated with a weaker operating environment and declining performance from key customers. Additionally, the expectation of divesting non-core assets in the near future could lead to deleveraging challenges and further financial strain.

PBH has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Prestige Brands Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Prestige Brands Holdings (PBH) Forecast

Analysts have given PBH a Buy based on their latest research and market trends.

According to 3 analysts, PBH has a Buy consensus rating as of Apr 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Prestige Brands Holdings (PBH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.